6 years fighting for a drug approval for duchenne MD
Issues and Challenges
Jenn has encountered: Rare / Underserved Disease, Geography, Medical Discrimination
In a nutshell, we fought for 6 years for a drug approval for duchenne MD, and now, I have exhausted all avenues for Max to receive masshealth coverage of either of his only two approved therapies, Exondys51 and Emflaza.
My Motivation and Inspiration
My 4 children. Austin 21, Max 18, James 13 and Norah 9, and all others who live with or love someone with a rare disease.
Austin and Max live with duchenne, James lives with congenital cholesteatoma and primary immune deficiency.